Research

Hormonal

In adults with obesity, GLP-1 receptor agonists demonstrate 15% to 20% weight loss.

GLP-1 receptor agonists can be considered effective for weight management in obese adults.

StrongSupportsmedium confidence
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists recently demonstrated 15% to 20% weight loss in adults with obesity.
Shohinee Sarma et al. · Obesity · 2022

Why this rating

The claim is supported by a systematic review and meta-analysis.

Source

Weight loss between glucagon‐like peptide‐1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta‐analysis

Shohinee Sarma et al. · Obesity · 2022

Meta-analysisCited 113×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →